These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1230489)

  • 1. [Ovarian hyperstimulation syndrome. Notes on the physiopathology and treatment apropos of 3 cases].
    Gayral MN; Millet D; Netter A
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):255-66. PubMed ID: 1230489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment.
    Engel T; Jewelewicz R; Dyrenfurth I; Speroff L; Vande Wiele RL
    Am J Obstet Gynecol; 1972 Apr; 112(8):1052-60. PubMed ID: 5017635
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of severe ovarian hyperstimulation syndrome after gonadotropin therapy.
    Moneta E; Garcea N; Scirpa P; Mango D
    Folia Endocrinol; 1974 Oct; 27(5):470-9. PubMed ID: 4480629
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome.
    Jewelewicz R; Vande Wiele RL
    Am J Obstet Gynecol; 1975 Apr; 121(8):1121. PubMed ID: 1119510
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian hyperstimulation: diagnosis and therapy.
    Cianci A; Roccasalva L; Agnello C; Riillo S; Palumbo G
    Acta Eur Fertil; 1989; 20(6):373-5. PubMed ID: 2488984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Right-sided hydrothorax--the only sign of ovarian hyperstimulation syndrome].
    Mannheimer B; Wramsby M
    Lakartidningen; 2007 Jan 17-23; 104(3):132-3. PubMed ID: 17302118
    [No Abstract]   [Full Text] [Related]  

  • 7. [The significance of the ovarian arteriolar vasodilatation in pathogenesis of the ovarian hyperstimulation syndrome].
    Vasiljević M; Prorocić M; Tasić L; Stanimirović B; Dikić S; Mandić V; Jeremić D
    Srp Arh Celok Lek; 2006; 134(7-8):344-7. PubMed ID: 17009617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report.
    Rabinerson D; Ben Rafael Z; Keslin J; Zolotarsky V; Dekel A
    J Reprod Med; 2001 Jan; 46(1):68-70. PubMed ID: 11209636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risks of ovarian overstimulation by administration of clomiphene and gonadotropins for ovulation stimulation].
    Hammerstein J
    Geburtshilfe Frauenheilkd; 1967 Dec; 27(12):1125-51. PubMed ID: 5627491
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of anovulatory sterility. IV. Ovarian hyperstimulation syndrome following the use of hypophyseal gonadotropins].
    León-Segura C; Canales ES; Zárate A; Soria J
    Ginecol Obstet Mex; 1973 Oct; 34(204):383-8. PubMed ID: 4775978
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe ovarian hyperstimulation syndrome. Case reports.
    Magnus O; Tanbo T; Henriksen T; Abyholm T
    Acta Eur Fertil; 1988; 19(2):89-92. PubMed ID: 3146850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ascites and hydrothorax due to endogenous hyperstimulation of H.C.G. in a case of hydatidiform mole destruens with secondary irreversible kidney insufficiency due to disseminated intravascular coagulation].
    Cappa F; Pasqua C; Tobia M; Ventura T
    Riv Ital Ginecol; 1976; 56(5-6):363-8. PubMed ID: 1019550
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax.
    Daniel Y; Yaron Y; Oren M; Peyser MR; Lessing JB
    Hum Reprod; 1995 Jul; 10(7):1684-5. PubMed ID: 8582961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ovarian hyperstimulation syndrome.
    Bettendorf G; Lindner C
    Horm Metab Res; 1987 Nov; 19(11):519-22. PubMed ID: 3323017
    [No Abstract]   [Full Text] [Related]  

  • 15. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiopathology of the renin-angiotensin system in the ovary.
    De Nuccio I; Salvati G; Genovesi G; Paolini P; Marcellini L; Schiavello V; Re M
    Minerva Endocrinol; 1999 Jun; 24(2):77-81. PubMed ID: 10941427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrothorax following ovarian hyperstimulation for assisted reproduction. Case report and review of the literature.
    Abbamonte LH; Remorgida V; Ferrero S; Ragni N; Anserini P
    Minerva Ginecol; 2007 Feb; 59(1):85-90. PubMed ID: 17353877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hyperstimulation syndrome.
    Shapiro AG; Thomas T; Epstein M
    Fertil Steril; 1977 Mar; 28(3):237-9. PubMed ID: 838096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach.
    Thaler I; Yoffe N; Kaftory JK; Brandes JM
    Fertil Steril; 1981 Jul; 36(1):110-3. PubMed ID: 6788611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.